Guaifenesin
34 brands · 28 companies · product forms
Opportunity snapshot
Who competes here
Top companies by brand count — fragmented market (no dominant player) · leader share 9%
Price room
Only 1 trusted price points; variation not scored (low data).
Brands & products on the market
Sample of 1 live product for Guaifenesin — each links to its own medicine page.
Why this score
Launch attractiveness
40% supply-gap(0) + 25% price-variation(0) + 20% low-competition(28) + 15% supply-disruption(0), damped by confidence(65). Higher = more attractive, less crowded opportunity.
Market saturation
28 canonical companies and 34 brands compete (saturation pegged at 30 companies / 150 brands).
Price room
Only 1 trusted price points; variation not scored (low data).
Regulatory risk
No DRAP alerts on this molecule's brands.
Confidence
Reduced by: sparse price data, no ATC code.
Packaged brief for this lower opportunity?
Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.
See packaged reports All 3868 molecules